Integra LifeSciences Holdings Corporation (FRA:IL3)

Market Cap	875.06M
Revenue (ttm)	1.40B
Net Income (ttm)	-422.17M
Shares Out	n/a
EPS (ttm)	-5.52
PE Ratio	n/a
Forward PE	5.63
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	42
Open	11.10
Previous Close	11.30
Day's Range	11.10 - 11.10
52-Week Range	9.45 - 25.40
Beta	n/a
RSI	52.22
Earnings Date	Feb 20, 2026

About FRA:IL3

Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamp...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1989
• Employees: 4,396
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: IL3

Financial Performance

Financial numbers in USD